A retrospective, single center study analyzing role of reduced dose of Ticagrelor in neuroendovascular patients
Latest Information Update: 22 Mar 2022
At a glance
- Drugs Ticagrelor (Primary)
- Indications Stroke; Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 22 Mar 2022 New trial record
- 11 Feb 2022 Results presented at the International Stroke Conference 2022